Europe Prefilled Syringes Market

The Europe prefilled syringes market is projected to reach USD 4.30 billion by 2030 from USD 2.63 billion in 2025, at a CAGR of 10.4% during the forecast period. Market growth is largely driven by the increasing prevalence of chronic diseases, the rising demand for self-administration, and the advantages of prefilled syringes, such as reduced risk of contamination and dosing errors. However, the presence of alternative drug delivery systems and stringent regulatory requirements limits the market growth of prefilled syringes.

The prominent players in the Europe prefilled syringes market are BD (US), Gerresheimer AG (Germany), SCHOTT (Germany), West Pharmaceutical Services, Inc. (US), AptarGroup Inc. (US), Nipro (Japan), and Baxter (US).

To know about the assumptions considered for the study download the pdf brochure

Key players in the Europe prefilled syringes market have adopted a mix of organic and inorganic growth strategies—such as product launches, acquisitions, collaborations, partnerships, agreements, and expansions—to enhance their global presence and increase market share. These initiatives have enabled them to expand geographically and deliver prefilled syringes across diverse regions.

In May 2025, Gerresheimer completed a EUR 100 million expansion and modernization of its Lohr site, highlighted by the installation of a new state-of-the-art oxy-hybrid glass furnace. The upgraded furnace increases production capacity, operates with up to 50% electricity, and reduces CO2e emissions by up to 40%, strengthening the site’s efficiency and sustainability.

In January 2025, SCHOTT Pharma introduced the next generation of SCHOTT TOPPAC infuse polymer syringes, enhancing safety, efficiency, and sustainability in healthcare.

In September 2024, BD increased production capacity at its site, Le Pont-de-Claix, France, facility, enhancing large-scale manufacturing capabilities for advanced glass syringes.

BD:

BD is a leading global medical technology company in the Europe prefilled syringes market, specializing in innovative medical devices, laboratory equipment, and injectable drug delivery solutions. BD’s products, including advanced prefilled syringes and safety-engineered systems, support improved clinical outcomes, enhance patient safety, and streamline healthcare workflows across hospitals, clinics, and pharmaceutical manufacturing. Becton, Dickinson and Company (BD) offers a broad portfolio spanning syringes, drug delivery systems, diagnostics, and clinical research tools, supporting healthcare across the care continuum. Its operations are organized into three segments—BD Medical, BD Life Sciences, and BD Interventional—with BD Medical focusing on medication delivery, management, and pharmaceutical systems. The company operates in more than 190 countries across North America, Latin America, Europe, the Middle East, Africa, and Asia.

Gerresheimer AG:

Gerresheimer is a leading player in the Europe prefilled syringes market and a global partner for pharmaceutical primary packaging and drug delivery solutions. The company offers a broad portfolio of prefillable syringes, vials, ampoules, insulin pens, inhalers, and other systems for the safe and convenient administration of drugs. With production sites and operations across 16 countries on three continents, Gerresheimer serves the pharmaceutical, biotechnology, healthcare, cosmetics, and food and beverage industries. Gerresheimer operates under 3 segments: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company has over 40 manufacturing plants across Europe, North America, South America, and Asia. Some of its notable subsidiaries include Gerresheimer Querétaro S.A. (Mexico), Gerresheimer Glass Inc. (US), and Gerresheimer Plásticos São Paulo Ltda. (Brazil), Kimble Chase (US), Gerresheimer Medical Plastic Systems Dongguan Co. Ltd. (China), and Triveni Polymers Pvt. Ltd. (India).

Schott:

Schott Pharma is a leading global supplier of pharmaceutical primary packaging and drug delivery solutions, specializing in glass and polymer containers for injectable drugs, in the Europe prefilled syringes market. As a subsidiary of SCHOTT, it supports pharmaceutical and biotech companies with high-quality, ready-to-use solutions for sensitive biologics and vaccines. SCHOTT develops, manufactures, and markets specialty glass materials and glass-ceramics. The company offers a broad portfolio of special glass, specialty materials, components, and systems. SCHOTT Group’s operations are organized into three different segments, i.e., Precision Materials, Optical Industries, and Home Appliances. The Pharma business unit in the Precision Materials segment offers syringes, vials, ampoules, and cartridges. Geographically, the company operates manufacturing sites and sales offices in 33 countries. Its operations span Europe, Asia, the Middle East and Africa, North America, and South America.

MARKET RANKING

In the Europe prefilled syringes market, the competitive landscape is shaped by a mix of leading multinational corporations and strong regional players. BD (US) holds a leading position, driven by its broad product portfolio, global distribution network, and trusted brand legacy. The company has sustained its leadership through continuous product innovation and consumer-focused marketing. Gerresheimer AG (Germany) is another major player, particularly in international markets. SCHOTT (Germany) also holds a significant share, offering a variety of products. Other notable companies include West Pharmaceutical Services, Inc. (US) and AptarGroup Inc. (US), which contribute to market diversity through differentiated formulations and expansive retail reach. Collectively, these players dominate the Europe prefilled syringes landscape, setting industry standards in formulation science, consumer trust, and global reach.

Related Reports:

Europe Prefilled Syringes Market by Type (Conventional, Safety), Material (Glass Prefilled Syringe, Plastic Syringe), Design (Single-chamber, Dual-chamber), Application (Diabetes, Cancer, Rheumatoid Arthritis, Other), & Country - Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com